Federal policy continues to expand its influence on drug pricing through mechanisms that indirectly affect the generics market. Enhanced drug price transparency, continued emphasis on generic substitution, and broader pricing reforms aimed at branded drugs all tend...
The U.S. federal government accounts for 10-13% or 15-20 billion per year of the total U.S. generic drug spending by dollars, despite representing a much higher share of volume. I spent three decades negotiating pharmaceutical contracts on the commercial side of the...
